Paper
Synthesis, structure and anticancer activity of novel 2,4-diamino-1,3,5-triazine derivatives.
Published Feb 1, 2006 · F. Sa̧czewski, A. Bułakowska, P. Bednarski
European journal of medicinal chemistry
Q2 SJR score
77
Citations
1
Influential Citations
Abstract
Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.
Study Snapshot
Novel 2,4-diamino-1,3,5-triazine derivatives show promising anticancer activity, with 2-[4-Amino-6-(4-phenylpiperazin-1-yl)-1,3,5-triazin-2-yl]-2[4-(
PopulationOlder adults (50-71 years)
Sample size24
MethodsObservational
OutcomesBody Mass Index projections
ResultsSocial networks mitigate obesity in older groups.
Sign up to use Study Snapshot
Consensus is limited without an account. Create an account or sign in to get more searches and use the Study Snapshot.
Full text analysis coming soon...
References
2-Hydroxy-4,6-diamino-[1,3,5]triazines: a novel class of VEGF-R2 (KDR) tyrosine kinase inhibitors.
2-Hydroxy-4,6-diamino-[1,3,5]triazines show potential as potent inhibitors of VEGF-R2 (flk-1/KDR) tyrosine kinase, with potential antiangiogenic activity and good in vitr
2005·46citations·N. Baindur et al.·Journal of medicinal chemistry
Journal of medicinal chemistry
Inhibition of Breast Cancer Regrowth and Pulmonary Metastasis in Nude Mice by Anti-gastric Ulcer Agent, Irsogladine
Irsogladine inhibits breast cancer regrowth and pulmonary metastasis in mice, suggesting it may be useful in the breast cancer adjuvant setting.
2004·23citations·S. Nozaki et al.·Breast Cancer Research and Treatment
Breast Cancer Research and Treatment
Synthesis and antitumor activity of novel 2-amino-4-(3,5,5-trimethyl-2-pyrazolino)-1,3,5-triazine derivatives.
Novel 2-amino-4-(3,5,5-trimethyl-2-pyrazolino)-1,3,5-triazine derivatives show modest to fairly high antitumor activity against various human tumor cell lines, with 2-[2-amino-4-(3,5,5-trimethyl-2-pyra
2002·49citations·Z. Brzozowski et al.·European journal of medicinal chemistry
European journal of medicinal chemistry
Synthesis, structural characterization and antitumor activity of novel 2,4-diamino-1,3,5-triazine derivatives.
Novel 2,4-diamino-1,3,5-triazine derivatives show moderate to strong antitumor activity, with 2-Amino-6-bromomethyl-4-(3,5,5-trimethyl-2-pyrazoline)-1,3,5-triazine 11 showing the most pot
2000·102citations·Z. Brzozowski et al.·European journal of medicinal chemistry
European journal of medicinal chemistry
An Information-Intensive Approach to the Molecular Pharmacology of Cancer
This study uses a unique compound activity pattern and molecular structural features to explore potential targets and modulators of anticancer activity in cancer cells, potentially generating new clinically active agents.
1997·1139citations·J. Weinstein et al.·Science
Science
Tyrphostins. 6. Dimeric benzylidenemalononitrile tyrophostins: potent inhibitors of EGF receptor tyrosine kinase in vitro.
Dimeric benzylidenemalononitrile tyrphostins are potent inhibitors of EGF receptor tyrosine kinase activity, offering potential for targeted therapy in cancer treatment.
1996·44citations·A. Gazit et al.·Journal of medicinal chemistry
Journal of medicinal chemistry
Tyrphostins. 5. Potent inhibitors of platelet-derived growth factor receptor tyrosine kinase: structure-activity relationships in quinoxalines, quinolines, and indole tyrphostins.
Quinoxalines and quinolines are more potent inhibitors of platelet-derived growth factor receptor tyrosine kinase than indoles, with lipophilic groups essential for their potency and selective activity against PDGF receptor.
1996·208citations·A. Gazit et al.·Journal of medicinal chemistry
Journal of medicinal chemistry
Inhibition of tumor growth and neovascularization by an anti-gastric ulcer agent, irsogladine.
Irsogladine, an anti-gastric ulcer agent, may be a potent inhibitor of tumor angiogenesis, potentially offering a new treatment for cancer.
1996·54citations·M. Ono et al.·Cancer research
Cancer research
HPLC determination of a new multidrug resistance modulator (S9788) extracted from cancer cells in vitro.
A new HPLC method developed for S9788 determination in P388 leukaemia cells enables rapid extraction and quantification of this novel multidrug resistance modulator.
1995·5citations·J. Tassin et al.·Talanta
Talanta
Citations
Design, Synthesis, Docking Studies and Molecular Dynamics Simulation of New 1,3,5‐Triazine Derivatives as Anticancer Agents Selectively Targeting Pancreatic Adenocarcinoma (Capan‐1)
New 1,3,5-triazine derivatives show promising anticancer activity, selectively targeting pancreatic adenocarcinoma (Capan-1) cells and promoting higher stability to prenyl-binding protein PDE.
2024·1citation·S. Asghar et al.·Chemistry & Biodiversity
Chemistry & Biodiversity
Divergent Synthesis of α-(1,3,5-Triazinylthio)-ketones and Thiazolo[3,2-a][1,3,5]triazines from 1,3-Dicarbonyl compounds or Chalcones with 1,3,5-Triazine-2-thiols.
This study developed an efficient method for synthesis of -(1,3,5-triazinylthio)-ketones and thiazolo[3,2-a][1,3,5]triazines from 1,3-dicarbonyl compounds or chalcones with 1,3,5
2023·0citations·Pengzhen Zhong et al.·The Journal of organic chemistry
The Journal of organic chemistry
Investigation of dipodal acetoguanamine-Schiff bases and their homonuclear FeIII complexes
Acetoguanamine-Schiff bases and their homonuclear FeIII complexes show weak antiferromagnetic exchange, with structures identified through elemental analysis, magnetic susceptibility, and spectral data.
2023·1citation·Gurkan Guney et al.·Journal of Coordination Chemistry
Journal of Coordination Chemistry
Selective Synthesis of N-[1,3,5]Triazinyl-α-Ketoamides and N-[1,3,5]Triazinyl-Amides from the Reactions of 2-Amine-[1,3,5]Triazines with Ketones
This study presents a selective approach for synthesizing N-[1,3,5]triazinyl--ketoamides and N-[1,3,5]triazinyl-amides from ketones with 2-amino[1,3,5]triazines under mild conditions, providing
2023·1citation·Yue Li et al.·Molecules
Molecules
Self-Associated 1,8-Naphthalimide as a Selective Fluorescent Chemosensor for Detection of High pH in Aqueous Solutions and Their Hg2+ Contamination
The novel 1,8-naphthalimide (NI-DAT) is a selective fluorescence chemosensor for detecting high pH in aqueous solutions and Hg2+ contamination, with good selectivity and sensitivity towards Hg2+.
2022·12citations·A. I. Said et al.·Sensors (Basel, Switzerland)
Sensors (Basel, Switzerland)